Figure 2From: Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy Comparative survival analyses between patients with greater and lesser PET-CT response. A: Overall survival (OS); B: Progression-free Survival (PFS); C: Local Regional Progression-free Survival (LRPFS). Solid line: greater SUVmax change; Dashed line: lesser SUVmax change.Back to article page